A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group

P. Pautier1*, A. Floquet2, L. Gladieff3, E. Bompas4, I. Ray-Coquard5, S. Piperno-Neumann6, F. Selle7, C. Guillemet8, B. Weber9, R. Largillier10, F. Bertucci11, P. Opinel12, F. Duffaud13, A. Reynaud-Bougnoux14, C. Delcambre15, N. Isambert16, P. Kerbrat17, G. Netter-Pinon18, N. Pinto19, P. Duvillard20, C. Haie-Meder21, C. Lhomme1 & A. Rey22 Department of Medical Oncology, Institut Gustave-Roussy, Villejuif; Department of Medical Oncology, Institut Bergonie, Bordeaux; Department of Medical Oncology, Institut Claudius-Regaud, Toulouse; Department of Medical Oncology, Centre Rene-Gauducheau, Nantes; Department of Medical Oncology, Centre Leon-Berard, Lyon; Department of Medical Oncology, Institut Curie, Paris; Department of Medical Oncology, Hopital Tenon, Paris; Department of Medical Oncology, Centre HenriBecquerel, Rouen; Department of Medical Oncology, Centre Alexis-Vautrin, Nancy; Department of Medical Oncology, Centre Antoine Laccassagne, Nice; Department of Medical Oncology, Institut Paoli Calmettes, Marseille; Department of Gynaecology, Centre Hospitalier du pays d’Aix, Aix en Provence; Department of Medical Oncology, La Timone University Hospital, Marseille; Department of Radiotherapy, Centre Bretonneau, Tours; Department of Medical Oncology, Centre Francois-Baclesse, Caen; Department of Medical Oncology, Centre Georges-Francois Leclerc, Dijon; Department of Medical Oncology, Centre Eugene-Marquis, Rennes; Department of Medical Oncology, Centre Hospitalier General, Meaux; Department of Radiotherapy, Centre de Haute Energie, Nice; Departments of Pathology; Radiotherapy; Biostatistics, Institut Gustave-Roussy, Villejuif, France